Trial Profile
Controlled Study of ONO-5920 in Patients With Involutional Osteoporosis in Japan.
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 06 Jun 2016
Price :
$35
*
At a glance
- Drugs Minodronic acid (Primary) ; Alendronic acid
- Indications Bone resorption; Osteoporosis; Postmenopausal osteoporosis
- Focus Adverse reactions; Therapeutic Use
- Sponsors Ono Pharmaceutical
- 05 Nov 2010 New trial record.